Mechanisms: Activates beta-3 adrenergic receptors to enhance fat breakdown without affecting muscle or bone metabolism
Food and Drug Administration (FDA) gave its nod of approval for Zepbound (tirzepatide) on November 8, as a new medication for chronic weight management in adults meeting the criteria for obesity
Benefits of REVIV B family vitamin shots Supports energy metabolism B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid) and B6 all contribute to the conversion of food into cellular energy, supporting daily vitality and helping to reduce tiredness and fatigue
While the exact mechanisms of action of Botox treatment for migraines remain uncovered, scientists believe that it prevents migraine headaches by blocking the transmission of pain signals along the nerves between the head and neck and brain, where migraine pain originates
Patients can also purchase ancillary supplies, like syringes and needles, and will have access to important patient-friendly instructional materials on correctly administering the medicine via needle and syringe
The complete side effect frequency breakdown from Phase 2 trials: Very Common (20%+ of patients at 12mg dose) Nausea: 28% Typically mild to moderate, peaks weeks 4-8, usually resolves by week 12 Diarrhea: 24% Usually transient (1-3 weeks), rarely severe Constipation: 21% Paradoxically coexists with diarrhea in different patients Common (10-20% of patients) Vomiting: 17% Decreased appetite: 16% (beyond therapeutic effect) Injection site reactions: 14% Fatigue: 13% Dyspepsia (indigestion): 12% Headache: 11% Uncommon (2-10% of patients) Abdominal pain: 8% Dizziness: 7% Gastroesophageal reflux: 6% Hypoglycemia in diabetics on other medications: 5% Increased heart rate (average 2-4 bpm): 4% Hair thinning/loss: 3% (typically temporary) Rare but Serious (Under 2%) Pancreatitis: 0.3% (3 cases out of 1,032 patients, all resolved with discontinuation) Gallbladder events: 1.4% (expected with rapid weight loss regardless of method) Acute kidney injury: 0.7% (all cases associated with severe dehydration) KEY TAKEAWAY: About 30% experience meaningful nausea in the first 4-8 weeks
